{"id":9802,"date":"2023-08-21T11:55:21","date_gmt":"2023-08-21T15:55:21","guid":{"rendered":"https:\/\/sliceofhealthcare.com\/?p=9802"},"modified":"2023-08-21T12:05:33","modified_gmt":"2023-08-21T16:05:33","slug":"genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing","status":"publish","type":"post","link":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/","title":{"rendered":"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"9802\" class=\"elementor elementor-9802\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7f5336a elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"7f5336a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2f80d41\" data-id=\"2f80d41\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c007790 elementor-widget elementor-widget-text-editor\" data-id=\"c007790\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Genesis Therapeutics, a pioneer in integrating artificial intelligence (AI) technologies for the development of innovative medicines for patients with severe diseases, has successfully closed an oversubscribed Series B financing round, raising $200 million. The company plans to use this capital to transition into a clinical stage entity, enhance its cutting-edge AI platform, and significantly expand its discovery pipeline.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-53265ad elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"53265ad\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b1fd0d8\" data-id=\"b1fd0d8\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-219a45b elementor-widget elementor-widget-heading\" data-id=\"219a45b\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 id=\"key-highlights\" class=\"elementor-heading-title elementor-size-default\">Key Highlights<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ea205cb elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"ea205cb\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-37761df\" data-id=\"37761df\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6d09b4b elementor-widget elementor-widget-text-editor\" data-id=\"6d09b4b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div><ul><li>The financing was co-led by a U.S.-based life-sciences-focused investor and returning investor Andreessen Horowitz (a16z) Bio + Health. Other participants included Fidelity Management & Research Company, BlackRock, NVIDIA\u2019s venture capital arm NVentures, and more.<\/li><li>The funds will be directed towards advancing Genesis’ AI-enabled programs into clinical development and further refining the Genesis Exploration of Molecular Space (GEMS) platform.<\/li><li>Genesis aims to address targets that are biologically validated but have been deemed undruggable due to complex chemistry challenges.<\/li><\/ul><\/div><p><b>Source:\u00a0<\/b><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230821419353\/en\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B\"><u>Business Wire<\/u><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e90ba87 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"e90ba87\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0c976b7\" data-id=\"0c976b7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5516a40 elementor-widget elementor-widget-heading\" data-id=\"5516a40\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 id=\"notable-quotes\" class=\"elementor-heading-title elementor-size-default\">Notable Quotes<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d697cb9 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"d697cb9\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0a4aada\" data-id=\"0a4aada\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-91b3c7e elementor-widget elementor-widget-text-editor\" data-id=\"91b3c7e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>“AI presents a potent opportunity to revolutionize the drug discovery process, which frequently struggles to produce viable drug candidates against targets that are biologically well-validated but considered undruggable due to highly challenging chemistry.” <strong>–<\/strong> <strong>Evan Feinberg, Ph.D., CEO of Genesis Therapeutics<\/strong><\/li><li>“Each new advance Genesis makes with their field-leading AI platform not only pushes technological boundaries but also brings hope to countless individuals awaiting medical breakthroughs.” <strong>–<\/strong> <strong>Vijay Pande, Ph.D., founding general partner at a16z Bio + Health<\/strong><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-de5db98 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"de5db98\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-49139f5\" data-id=\"49139f5\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-416ad5a elementor-widget elementor-widget-heading\" data-id=\"416ad5a\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 id=\"sohs-take\" class=\"elementor-heading-title elementor-size-default\">SoH's Take<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-815da73 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"815da73\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-123f65b\" data-id=\"123f65b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e1455ae elementor-widget elementor-widget-text-editor\" data-id=\"e1455ae\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Genesis Therapeutics’ integration of AI in drug discovery signifies a transformative approach in the biotech industry. Their focus on addressing previously undruggable targets using AI could potentially lead to groundbreaking medical solutions.<\/li><li>The oversubscribed Series B round, coupled with the participation of notable investors, underscores the industry’s confidence in Genesis’ vision and technology. As AI continues to reshape the medical landscape, Genesis is well-positioned to be at the forefront of this revolution.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"Genesis Therapeutics, a pioneer in integrating artificial intelligence (AI) technologies for the development of innovative medicines for patients…\n","protected":false},"author":1,"featured_media":9803,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","pgc_sgb_lightbox_settings":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1916,1896],"tags":[2034,2036,2038,2035,2033,2037,2039],"class_list":["post-9802","post","type-post","status-publish","format-standard","has-post-thumbnail","category-funding-news","category-news","tag-a16z","tag-blackrock","tag-evan-feinberg","tag-fidelity-management-research-company","tag-genesis-therapeutics","tag-nventures","tag-vijay-pande","cs-entry","cs-video-wrap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.6 (Yoast SEO v24.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing<\/title>\n<meta name=\"description\" content=\"Genesis Therapeutics secures an oversubscribed $200 million Series B funding, emphasizing its commitment to leveraging AI in revolutionizing drug discovery and addressing previously undruggable targets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing\" \/>\n<meta property=\"og:description\" content=\"Genesis Therapeutics secures an oversubscribed $200 million Series B funding, emphasizing its commitment to leveraging AI in revolutionizing drug discovery and addressing previously undruggable targets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"Slice of Healthcare\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-21T15:55:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-21T16:05:33+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jared S. Taylor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SliceofHC\" \/>\n<meta name=\"twitter:site\" content=\"@SliceofHC\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jared S. Taylor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/\"},\"author\":{\"name\":\"Jared S. Taylor\",\"@id\":\"https:\/\/sliceofhealthcare.com\/#\/schema\/person\/b8952cd8876a00a704e63015150f15da\"},\"headline\":\"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing\",\"datePublished\":\"2023-08-21T15:55:21+00:00\",\"dateModified\":\"2023-08-21T16:05:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/\"},\"wordCount\":308,\"publisher\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1\",\"keywords\":[\"a16z\",\"BlackRock\",\"Evan Feinberg\",\"Fidelity Management & Research Company\",\"Genesis Therapeutics\",\"NVentures\",\"Vijay Pande\"],\"articleSection\":[\"Funding News\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/\",\"url\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/\",\"name\":\"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing\",\"isPartOf\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1\",\"datePublished\":\"2023-08-21T15:55:21+00:00\",\"dateModified\":\"2023-08-21T16:05:33+00:00\",\"description\":\"Genesis Therapeutics secures an oversubscribed $200 million Series B funding, emphasizing its commitment to leveraging AI in revolutionizing drug discovery and addressing previously undruggable targets.\",\"breadcrumb\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sliceofhealthcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sliceofhealthcare.com\/#website\",\"url\":\"https:\/\/sliceofhealthcare.com\/\",\"name\":\"Slice of Healthcare\",\"description\":\"Redefining Healthcare Media.\",\"publisher\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sliceofhealthcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sliceofhealthcare.com\/#organization\",\"name\":\"Slice of Healthcare\",\"url\":\"https:\/\/sliceofhealthcare.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sliceofhealthcare.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2022\/02\/New-large-logo-for-slice-of-healthcare-website-2x-160-%C3%97-160-px.png?fit=160%2C160&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2022\/02\/New-large-logo-for-slice-of-healthcare-website-2x-160-%C3%97-160-px.png?fit=160%2C160&ssl=1\",\"width\":160,\"height\":160,\"caption\":\"Slice of Healthcare\"},\"image\":{\"@id\":\"https:\/\/sliceofhealthcare.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/SliceofHC\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/sliceofhealthcare.com\/#\/schema\/person\/b8952cd8876a00a704e63015150f15da\",\"name\":\"Jared S. Taylor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sliceofhealthcare.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/04bd3f0ad54088c77a042893bc30b559?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/04bd3f0ad54088c77a042893bc30b559?s=96&d=mm&r=g\",\"caption\":\"Jared S. Taylor\"},\"url\":\"https:\/\/sliceofhealthcare.com\/author\/jared\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing","description":"Genesis Therapeutics secures an oversubscribed $200 million Series B funding, emphasizing its commitment to leveraging AI in revolutionizing drug discovery and addressing previously undruggable targets.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/","og_locale":"en_US","og_type":"article","og_title":"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing","og_description":"Genesis Therapeutics secures an oversubscribed $200 million Series B funding, emphasizing its commitment to leveraging AI in revolutionizing drug discovery and addressing previously undruggable targets.","og_url":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/","og_site_name":"Slice of Healthcare","article_published_time":"2023-08-21T15:55:21+00:00","article_modified_time":"2023-08-21T16:05:33+00:00","og_image":[{"width":1280,"height":720,"url":"http:\/\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png","type":"image\/png"}],"author":"Jared S. Taylor","twitter_card":"summary_large_image","twitter_creator":"@SliceofHC","twitter_site":"@SliceofHC","twitter_misc":{"Written by":"Jared S. Taylor","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#article","isPartOf":{"@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/"},"author":{"name":"Jared S. Taylor","@id":"https:\/\/sliceofhealthcare.com\/#\/schema\/person\/b8952cd8876a00a704e63015150f15da"},"headline":"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing","datePublished":"2023-08-21T15:55:21+00:00","dateModified":"2023-08-21T16:05:33+00:00","mainEntityOfPage":{"@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/"},"wordCount":308,"publisher":{"@id":"https:\/\/sliceofhealthcare.com\/#organization"},"image":{"@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1","keywords":["a16z","BlackRock","Evan Feinberg","Fidelity Management & Research Company","Genesis Therapeutics","NVentures","Vijay Pande"],"articleSection":["Funding News","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/","url":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/","name":"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing","isPartOf":{"@id":"https:\/\/sliceofhealthcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#primaryimage"},"image":{"@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1","datePublished":"2023-08-21T15:55:21+00:00","dateModified":"2023-08-21T16:05:33+00:00","description":"Genesis Therapeutics secures an oversubscribed $200 million Series B funding, emphasizing its commitment to leveraging AI in revolutionizing drug discovery and addressing previously undruggable targets.","breadcrumb":{"@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#primaryimage","url":"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1","contentUrl":"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/sliceofhealthcare.com\/genesis-therapeutics-closes-oversubscribed-200-million-series-b-financing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sliceofhealthcare.com\/"},{"@type":"ListItem","position":2,"name":"Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing"}]},{"@type":"WebSite","@id":"https:\/\/sliceofhealthcare.com\/#website","url":"https:\/\/sliceofhealthcare.com\/","name":"Slice of Healthcare","description":"Redefining Healthcare Media.","publisher":{"@id":"https:\/\/sliceofhealthcare.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sliceofhealthcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/sliceofhealthcare.com\/#organization","name":"Slice of Healthcare","url":"https:\/\/sliceofhealthcare.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sliceofhealthcare.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2022\/02\/New-large-logo-for-slice-of-healthcare-website-2x-160-%C3%97-160-px.png?fit=160%2C160&ssl=1","contentUrl":"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2022\/02\/New-large-logo-for-slice-of-healthcare-website-2x-160-%C3%97-160-px.png?fit=160%2C160&ssl=1","width":160,"height":160,"caption":"Slice of Healthcare"},"image":{"@id":"https:\/\/sliceofhealthcare.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/SliceofHC"]},{"@type":"Person","@id":"https:\/\/sliceofhealthcare.com\/#\/schema\/person\/b8952cd8876a00a704e63015150f15da","name":"Jared S. Taylor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sliceofhealthcare.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/04bd3f0ad54088c77a042893bc30b559?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/04bd3f0ad54088c77a042893bc30b559?s=96&d=mm&r=g","caption":"Jared S. Taylor"},"url":"https:\/\/sliceofhealthcare.com\/author\/jared\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/sliceofhealthcare.com\/wp-content\/uploads\/2023\/08\/Genesis-Therapeutics-Closes-Oversubscribed-200-Million-Series-B-Financing.png?fit=1280%2C720&ssl=1","jetpack-related-posts":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/posts\/9802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/comments?post=9802"}],"version-history":[{"count":5,"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/posts\/9802\/revisions"}],"predecessor-version":[{"id":9810,"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/posts\/9802\/revisions\/9810"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/media\/9803"}],"wp:attachment":[{"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/media?parent=9802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/categories?post=9802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sliceofhealthcare.com\/wp-json\/wp\/v2\/tags?post=9802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}